Key facts
- This page summarizes Douglas M. van Oort's Form 4 filing for NEOGENOMICS INC (NEO).
- 1 reported transaction and 3 derivative rows are listed below.
- Accepted by SEC: 13 Aug 2021, 17:12.
Douglas M. van Oort - 01 Aug 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)
- Reporting relationship
- Director
- Issuer ticker
- NEO
- Reported as of
- 01 Aug 2021
- Net transaction value
- -$272,866
- SEC form
- 4
- Accepted by SEC
- 13 Aug 2021, 17:12:39 UTC
- Next SEC filing
- 27 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Douglas M. VanOort
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Douglas M. van Oort filed Form 4 for NEOGENOMICS INC (NEO) on 13 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$272,866.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEO
transaction
Common Stock
Tax liability
- Transaction value
- $272,866
- Shares
- -5,919
- Change %
- -0.24%
- Price
- $46.10
- Shares after
- 2,468,797
- Date
- 01 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
NEO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,000
- Date
- 01 Aug 2021
- Ownership
- Custodial Account for Child
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500,000
- Date
- 01 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500,000
- Exercise price
- $8.03
- Footnotes
- F2
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 231,567
- Date
- 01 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 231,567
- Exercise price
- $19.60
- Footnotes
- F3
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 225,084
- Date
- 01 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 225,084
- Exercise price
- $28.33
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the August 1, 2021 vesting of restricted stock.
Footnote F2
On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
Footnote F3
On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F4
On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.